Shanghai New Asiatic Medicine Industry Minhang Co., Ltd.
-
Founded in:
1989-07-06 -
Country:
China -
Address:
No. 1500, Kunyang Road, Minhang District, Shanghai -
Tax NO.:
91310112133354160Q -
Registered Funds:
57.5 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ciprofloxacin hydrochloride |
This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacilli. It has good antibacterial activity in vitro against the following bacteria: most bacteria of the Enterobacteriaceae family, including Citrobacter, cloacae, Enterobacter aerogenes, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. It often has antibacterial activity against multi-drug resistant bacteria. It has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing Haemophilus influenzae and Moraxella. It has antibacterial activity against most strains of Pseudomonas such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive Staphylococcus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It also has good effects on Chlamydia trachomatis, Mycoplasma, Legionella, and antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. Poor antibacterial activity against anaerobic bacteria. Ciprofloxacin is a bactericide that acts on the A subunit of bacterial DNA gyrase, inhibiting DNA synthesis and replication, leading to bacterial death.
More
This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacilli. It has good antibacterial activity in vitro against the following bacteria: most bacteria of the Enterobacteriaceae family, including Citrobacter, cloacae, Enterobacter aerogenes, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. It often has antibacterial activity against multi-drug resistant bacteria. It has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing Haemophilus influenzae and Moraxella. It has antibacterial activity against most strains of Pseudomonas such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive Staphylococcus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It also has good effects on Chlamydia trachomatis, Mycoplasma, Legionella, and antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. Poor antibacterial activity against anaerobic bacteria. Ciprofloxacin is a bactericide that acts on the A subunit of bacterial DNA gyrase, inhibiting DNA synthesis and replication, leading to bacterial death. |
93107-08-5 | 37 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Enalapril maleate |
Angiotensin converting enzyme inhibitor. After oral administration, it is hydrolyzed into Enalaprilat in the body, which strongly inhibits angiotensin converting enzyme, reduces the content of angiotensin II, causes systemic vasodilation, and causes blood pressure reduction. It has a significant antihypertensive effect on dinephrogenic hypertension, mononephrogenic hypertension and spontaneous hypertension rat models.
More
Angiotensin converting enzyme inhibitor. After oral administration, it is hydrolyzed into Enalaprilat in the body, which strongly inhibits angiotensin converting enzyme, reduces the content of angiotensin II, causes systemic vasodilation, and causes blood pressure reduction. It has a significant antihypertensive effect on dinephrogenic hypertension, mononephrogenic hypertension and spontaneous hypertension rat models. |
76095-16-4 | 34 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Enalapril maleate |
Angiotensin converting enzyme inhibitor. After oral administration, it is hydrolyzed into Enalaprilat in the body, which strongly inhibits angiotensin converting enzyme, reduces the content of angiotensin II, causes systemic vasodilation, and causes blood pressure reduction. It has a significant antihypertensive effect on dinephrogenic hypertension, mononephrogenic hypertension and spontaneous hypertension rat models.
More
Angiotensin converting enzyme inhibitor. After oral administration, it is hydrolyzed into Enalaprilat in the body, which strongly inhibits angiotensin converting enzyme, reduces the content of angiotensin II, causes systemic vasodilation, and causes blood pressure reduction. It has a significant antihypertensive effect on dinephrogenic hypertension, mononephrogenic hypertension and spontaneous hypertension rat models. |
76095-16-4 | 34 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Cefpodoxime proxetil |
It has strong antibacterial activity against Staphylococcus, Streptococcus, Pneumococcus, Peptostreptococcus, Gonorrhea, Branhamella catarrhalis, Escherichia coli, Klebsiella, Proteus (Proteus mirabilis, Proteus vulgaris, Providencia rettgeri, Providencia anomala), Citrobacter, Enterobacter, and Haemophilus influenzae.
More
It has strong antibacterial activity against Staphylococcus, Streptococcus, Pneumococcus, Peptostreptococcus, Gonorrhea, Branhamella catarrhalis, Escherichia coli, Klebsiella, Proteus (Proteus mirabilis, Proteus vulgaris, Providencia rettgeri, Providencia anomala), Citrobacter, Enterobacter, and Haemophilus influenzae. |
87239-81-4 | 28 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Venlafaxine hydrochloride |
This product mainly exerts its antidepressant effect by inhibiting the reuptake of serotonin and norepinephrine by the central nervous system, thereby increasing the concentration of these two monoamine transmitters in the synaptic cleft.
More
This product mainly exerts its antidepressant effect by inhibiting the reuptake of serotonin and norepinephrine by the central nervous system, thereby increasing the concentration of these two monoamine transmitters in the synaptic cleft. |
99300-78-4 | 88 |